| Primary |
| Type 2 Diabetes Mellitus |
36.9% |
| Product Used For Unknown Indication |
25.3% |
| Type 1 Diabetes Mellitus |
8.2% |
| Hypertension |
6.5% |
| Diabetes Mellitus |
5.5% |
| Gestational Diabetes |
4.1% |
| Glaucoma |
2.7% |
| Asthma |
2.0% |
| Hypothyroidism |
1.7% |
| Cardiac Disorder |
1.4% |
| Anxiety |
1.0% |
| Blood Cholesterol Abnormal |
0.7% |
| Depression |
0.7% |
| Dyslipidaemia |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Prophylaxis |
0.7% |
| Angina Pectoris |
0.3% |
| Benign Prostatic Hyperplasia |
0.3% |
| Blood Cholesterol Increased |
0.3% |
| Cardiovascular Event Prophylaxis |
0.3% |
|
| Hypoglycaemia |
10.4% |
| Blood Glucose Increased |
8.3% |
| Premature Baby |
8.3% |
| Weight Increased |
8.3% |
| Wrong Technique In Drug Usage Process |
8.3% |
| Exposure During Pregnancy |
6.3% |
| Loss Of Consciousness |
6.3% |
| Product Quality Issue |
6.3% |
| Hospitalisation |
4.2% |
| Malaise |
4.2% |
| Premature Delivery |
4.2% |
| Sinusitis |
4.2% |
| Syncope |
4.2% |
| Weight Decreased |
4.2% |
| Blindness |
2.1% |
| Cardiac Failure Congestive |
2.1% |
| Cataract |
2.1% |
| Cerebral Infarction |
2.1% |
| Cerebrovascular Accident |
2.1% |
| Coma |
2.1% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
50.3% |
| Gestational Diabetes |
7.3% |
| Hypertension |
7.3% |
| Product Used For Unknown Indication |
6.8% |
| Type 1 Diabetes Mellitus |
6.8% |
| Dyslipidaemia |
5.2% |
| Diabetes Mellitus |
4.7% |
| Glaucoma |
4.2% |
| Cardiac Disorder |
2.1% |
| Blood Cholesterol Abnormal |
1.0% |
| Anxiety |
0.5% |
| Blood Glucose Fluctuation |
0.5% |
| Hypothyroidism |
0.5% |
| Labyrinthitis |
0.5% |
| Pre-eclampsia |
0.5% |
| Prophylaxis |
0.5% |
| Thyroid Disorder |
0.5% |
| Urinary Incontinence |
0.5% |
|
| Respiratory Distress |
18.2% |
| Premature Baby |
9.1% |
| Product Quality Issue |
9.1% |
| Pre-eclampsia |
6.8% |
| Tooth Abscess |
6.8% |
| Device Malfunction |
4.5% |
| Exposure During Pregnancy |
4.5% |
| Myocardial Infarction |
4.5% |
| Panniculitis |
4.5% |
| Premature Delivery |
4.5% |
| Syncope |
4.5% |
| Weight Increased |
4.5% |
| Blood Glucose Increased |
2.3% |
| Breast Cancer |
2.3% |
| Cellulitis |
2.3% |
| Coma |
2.3% |
| Epistaxis |
2.3% |
| Foetal Exposure During Pregnancy |
2.3% |
| Hyperglycaemia |
2.3% |
| Hypoglycaemia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.0% |
| Type 2 Diabetes Mellitus |
14.0% |
| Diabetes Mellitus |
10.2% |
| Drug Use For Unknown Indication |
7.2% |
| Drug Therapy |
6.0% |
| Nausea |
6.0% |
| Vomiting |
5.1% |
| Hypertension |
4.7% |
| Muscle Spasms |
3.0% |
| Pain |
3.0% |
| Atrial Fibrillation |
2.1% |
| Blood Cholesterol Increased |
2.1% |
| Depression |
2.1% |
| Vitamin Supplementation |
2.1% |
| Coronary Artery Disease |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Hyperlipidaemia |
1.7% |
| Type 1 Diabetes Mellitus |
1.7% |
| Alpha-1 Anti-trypsin Deficiency |
1.3% |
| Cardiac Disorder |
1.3% |
|
| Pancreatitis |
11.1% |
| Hepatocellular Carcinoma |
7.4% |
| Pneumonia Respiratory Syncytial Viral |
7.4% |
| Renal Failure Acute |
7.4% |
| Type 2 Diabetes Mellitus |
7.4% |
| Vomiting |
7.4% |
| Abdominal Pain |
3.7% |
| Arthropathy |
3.7% |
| Blindness |
3.7% |
| Bradycardia |
3.7% |
| Cholestasis |
3.7% |
| Drug Hypersensitivity |
3.7% |
| Flatulence |
3.7% |
| Intentional Overdose |
3.7% |
| International Normalised Ratio Decreased |
3.7% |
| Lipase Increased |
3.7% |
| Malaise |
3.7% |
| Mental Status Changes |
3.7% |
| Metabolic Acidosis |
3.7% |
| Nausea |
3.7% |
|
